Diabetes

News

Lilly partners with Rimidi on digital diabetes management to...

Pharmaceutical companies in the diabetes market are all investing in tech to help doctors and patients manage the condition.

Sanofi turns the tables on Lilly with biosimilar fast-acting...

Big-selling Humalog facing cut price competition

News

Novo aiming for blockbuster sales for FDA-approved semagluti...

Novo Nordisk’s weekly GLP-1 diabetes injection semaglutide has been approved by the US regulator, a potential blockbuster that the firm hopes will allow it to regain market share from Lilly

News

Dance Biopharm to develop inhaled insulin with Phillips-Medi...

Biotech working on soft mist insulin delivery device with IT firm

News

Lilly looks to devices to revive diabetes division

Dexcom continuous glucose monitors to become part of Lilly's Connected Devices Ecosystem.

News

Sanofi looks to Dupixent as diabetes sales plummet

Dupixent off to strong start after US launch

Lilly partners with Rimidi on digital diabetes management to...

Sanofi turns the tables on Lilly with biosimilar fast-acting...

Novo aiming for blockbuster sales for FDA-approved semagluti...

Dance Biopharm to develop inhaled insulin with Phillips-Medi...

Lilly looks to devices to revive diabetes division

Sanofi looks to Dupixent as diabetes sales plummet

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Diabetes

Editor's Picks